Cell in Cells

Regenerative Longevity

Seoul, South Korea · Founded 2014 · $19.2M raised

Headquarters
Seoul
Employees
11–50
Founded
2014
Business Model
B2B
Total Funding
$19.2M
Rounds
5

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 5 funding rounds for this company. The full record is or through the API.

About

CELLinCELLS (Cell in Cells) is a Seoul-based regenerative medicine biotech company founded in 2014, focused on developing therapeutic organoid products for the longevity and regenerative medicine market. The company's core platform is the 3D Tissue-Reforming Technology Platform (TRTP), which uses a proprietary concave cup-shaped organoid structure to enable nutrient and oxygen delivery to organoid centers — overcoming size limitations common in conventional methods. Its pipeline includes organoid skin regenerative therapy for atrophic scars (IND approved 2023, clinical administration completed 2024), cartilage organoid therapy for osteoarthritis, and a range of organoid-derived biomaterials and medical products. The company also applies AI deep learning to predict and evaluate organoid production quality.

Summary

Cell in Cells is a Biotech company based in Seoul, South Korea, founded in 2014. It has raised $19.2M in total across 5 rounds.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries A
$2.5M

Sign up to see all 5 events

Funding, valuations, and company events, with amounts and investors where available.

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Cell in Cells on Indexed.vc
<a href="https://indexed.vc/companies/cell-in-cells"><img src="https://indexed.vc/api/badge/company/cell-in-cells" alt="Cell in Cells on Indexed.vc" width="260" height="76" /></a>